Literature DB >> 26082192

The Role of miR-21 in Cancer.

Susan R Pfeffer1, Chuan He Yang1, Lawrence M Pfeffer1.   

Abstract

MicroRNAs (miRNAs) are small endogenous noncoding RNAs that suppress gene expression at the post-transcriptional level. In the past decade, miRNAs have been extensively studied in a number of different human cancers. MiRNAs have been identified to act both as oncogenes and as tumor suppressors. In addition, miRNAs are associated with the intrinsic resistance of cancer to various forms of therapy, and they are implicated in both tumor progression and metastasis. The characterization of the specific alterations in the patterns of miRNA expression in cancer has great potential for identifying biomarkers for early cancer detection, as well as for potential therapeutic intervention in cancer treatment. In this chapter, we describe the ever-expanding role of miR-21 and its target genes in different cancers, and provide insight into how this oncogenic miRNA regulates cancer cell proliferation, migration, and apoptosis by suppressing the expression of tumor suppressors.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  FBX011; IGFBP3; cancer; miR-21; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26082192     DOI: 10.1002/ddr.21257

Source DB:  PubMed          Journal:  Drug Dev Res        ISSN: 0272-4391            Impact factor:   4.360


  111 in total

Review 1.  Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.

Authors:  Tae Jin Lee; Xiaoyi Yuan; Keith Kerr; Ji Young Yoo; Dong H Kim; Balveen Kaur; Holger K Eltzschig
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

2.  miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation.

Authors:  Chiu-Chun Chang; Chun-Che Lin; Chia-Hung Wang; Chi-Chou Huang; Tao-Wei Ke; Po-Li Wei; Ken-Tu Yeh; Kai-Cheng Hsu; Nan-Yung Hsu; Ya-Wen Cheng
Journal:  Oncol Lett       Date:  2018-03-19       Impact factor: 2.967

3.  Species-specific function of microRNA-7702 in human colorectal cancer cells via targeting TADA1.

Authors:  Han Liu; Dongdong Li; Hua Fang; Junnan Ning
Journal:  Am J Transl Res       Date:  2018-08-15       Impact factor: 4.060

4.  In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21.

Authors:  Yuan Li; Zhong Li; Yunhao Jia; Bo Ding; Jinsong Yu
Journal:  Dig Dis Sci       Date:  2019-09-26       Impact factor: 3.199

5.  MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles.

Authors:  W He; C Wang; R Mu; P Liang; Z Huang; J Zhang; L Dong
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

Review 6.  MicroRNA regulation of F-box proteins and its role in cancer.

Authors:  Zhao-Hui Wu; Lawrence M Pfeffer
Journal:  Semin Cancer Biol       Date:  2015-10-01       Impact factor: 15.707

7.  LncRNA NBR2 suppresses migration and invasion of colorectal cancer cells by downregulating miRNA-21.

Authors:  Jinghui Bai; Jian Xu; Jian Zhao; Rui Zhang
Journal:  Hum Cell       Date:  2019-10-01       Impact factor: 4.174

Review 8.  MicroRNAs: Key Players in Bladder Cancer.

Authors:  Qi Li; Helei Wang; Hourong Peng; Qiuping Huang; Ting Huyan; Qingsheng Huang; Hui Yang; Junling Shi
Journal:  Mol Diagn Ther       Date:  2019-10       Impact factor: 4.074

9.  MiR-21 Suppresses Anoikis through Targeting PDCD4 and PTEN in Human Esophageal Adenocarcinoma.

Authors:  Meng-Ya Zhao; La-Mei Wang; Jing Liu; Xing Huang; Jing Liu; Ya-Fei Zhang
Journal:  Curr Med Sci       Date:  2018-04-30

Review 10.  PD-1/PD-L1 pathway: current researches in cancer.

Authors:  Yanyan Han; Dandan Liu; Lianhong Li
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.